Steroid-responsive proximal myopathy with dystrophic muscle biopsy in a young male
a diagnostic dilemma
DOI:
https://doi.org/10.59736/IJP.23.04.1017Keywords:
Electromyography, Limb Girdle Muscular Dystrophy, Myopathy, Polymyositis, Proximal Muscle Biopsy, Serum Creatine PhosphokinaseAbstract
Background: Limb Girdle Muscular Dystrophy Type 2B (LGMD2B) can closely mimic polymyositis, particularly in young adults and may show misleading short-term steroid responsiveness. However, unlike inflammatory myopathies, they do not benefit from long-term immunosuppression, which may in fact accelerate muscle degeneration. Case report: We report the case of a 21-year-old male presenting with acute-onset progressive proximal muscle weakness and markedly elevated creatine phosphokinase levels. The clinical picture, along with a transient response to corticosteroids, initially suggested inflammatory myopathy of polymyositis. However, muscle biopsy revealed dystrophic features with minimal inflammation and autoimmune serologies were negative, suggesting an underlying muscular dystrophy, specifically LGMD2B. Conclusion: This case underscores the importance of a comprehensive diagnostic approach in patients with proximal myopathy. Overreliance on steroid responsiveness or elevated CPK levels can lead to misdiagnosis. Differentiating muscular dystrophies from inflammatory myopathies is essential to avoid unnecessary immunosuppression.
References
Arab F, Ahangari N, Malek H, Doosti M, Najarzadeh-Torbati P, Ghayoor-Karimiani E. Limb-girdle muscular dystrophy type 2B (LGMD2B) caused by pathogenic splice and missense variants of DYSF gene among Iranians with muscular dystrophy. Adv Biomed Res. 2023; 12:150. doi: 10.4103/abr.abr_131_22.
Poudel BH, Fletcher S, Wilton SD, Aung-Htut M. Limb girdle muscular dystrophy type 2B (LGMD2B): diagnosis and therapeutic possibilities. Int J Mol Sci. 2024;25(11):5572. doi:10.3390/ijms25115572.
Wang Y, Tadayon R, Santamaria L, Mercier P, Forristal CJ, Shaw GS. Calcium binds and rigidifies the dysferlin C2A domain in a tightly coupled manner. Biochem J. 2021;478(1):197-215. doi:10.1042/BCJ20200773.
Muriel J, Lukyanenko V, Kwiatkowski T, Bhattacharya S, Garman D, Weisleder N, et al. The C2 domains of dysferlin: roles in membrane localization, Ca²⁺ signalling and sarcolemmal repair. J Physiol. 2022;600(8):1953-68. doi:10.1113/JP282648.
Özyilmaz B, Kirbiyik Ö, Özdemir TR, Kaya-Özer Ö, Kutbay YB, Erdogan KM, et al. Impact of next-generation sequencing panels in the evaluation of limb-girdle muscular dystrophies. Ann Hum Genet. 2019;83(5):331-47. doi:10.1111/ahg.12319.
Izumi R, Takahashi T, Suzuki N, Niihori T, Ono H, Nakamura N, et al. The genetic profile of dysferlinopathy in a cohort of 209 cases: genotype-phenotype relationship and a hotspot on the inner DysF domain. Hum Mutat. 2020;41(9):1540-54. doi:10.1002/humu.24036.
Hunter M, Heatwole C, Wicklund M, Weihl CC, Mozaffar T, Statland JM, et al. Limb-girdle muscular dystrophy: a perspective from adult patients on what matters most. Muscle Nerve. 2019;60(4):419-24. doi:10.1002/mus.26636.
Younus M, Ahmad F, Malik E, Bilal M, Kausar M, Abbas S, et al. SGCD homozygous nonsense mutation (p.Arg97*) causing limb-girdle muscular dystrophy type 2F (LGMD2F) in a consanguineous family: a case report. Front Genet. 2019;9:727. doi:10.3389/fgene.2018.00727.
Zhong H, Yu M, Lin P, Zhao Z, Zheng X, Xi J, et al. Molecular landscape of DYSF mutations in dysferlinopathy: from a Chinese multicenter analysis to a worldwide perspective. Hum Mutat. 2021;42(12):1615-23. doi:10.1002/humu.24284.
Zhang H, Li Y, Cheng Q, Chen X, Yu Q, Li Z. Abnormal expression of dysferlin in blood monocytes supports primary dysferlinopathy in patients confirmed by genetic analyses. Front Neurol. 2021; 11:540098. doi:10.3389/fneur.2020.540098.
Vallecillo-Zúniga ML, Rathgeber MF, Poulson PD, Hayes S, Luddington JS, Gill HN, et al. Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models. PLoS One. 2020;15(9): e0238441. doi: 10.1371/journal.pone.0238441.
Pozsgai E, Griffin D, Potter R, Sahenk Z, Lehman K, Rodino-Klapac LR, et al. Unmet needs and evolving treatment for limb-girdle muscular dystrophies. Neurodegener Dis Manag. 2021;11(5):411-29. doi:10.2217/nmt-2020-0066.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Nauman Ismat Butt, Muhammad Sohail Ajmal Ghoauri
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
